2019BWB - China Focus@BWB

China Focus @ BWB

Sept 10, 2019

Boston Convention and Exhibition Center

Rooms 254 & 255
415 Summer St, Boston, MA 02210

PART OF Biotech Week Boston

ABOUT CHINA FOCUS @BWB

China has embraced a vigorously growing healthcare market in the past decade. Ever since joining ICH in 2017, China has seen increased clinical trials and accelerated new drug and device approval. For biotech and MedTech companies outside of China, you need to find the right partners and the right resources to bring your products to China, in order to adapt to the difference in culture, regulation, reimbursement, etc. In the meantime, Chinese biotechs are actively seeking global market entry opportunities and oversea partners.

China Focus @BWB is designed to provide a meaningful platform to inform, inspire, and foster cross-border partnership in life science and healthcare.

Who should attend

Investors (VC, PE, investment bank, etc.)
Life science innovators and entrepreneurs
Biotech & big pharma
Medtech (device and diagnostics) manufacturers and distributors
Service providers (law firm, financial advisory, regulatory consulting, CRO, CDMO, etc.)
Healthcare providers

Main topics

Regulatory reforms in China and the impact on cross-border partnership
Chines biopharma’s strategies to meet the domestic and global needs for innovation
Join forces in a global battle again cancer
Cell and gene therapy – opportunities for collaboration
Winning recipes in a competitive landscape of licensing

What you can get

Learn about Chinese life science and healthcare industry
Hear about the latest Chinese regulatory reforms and implications
Meet with the decision makers in the industry
Initiate business conversations that otherwise difficult to start

ATTENDEE DEMOGRAPHICS

at Previous China Focus Events

Attendees

%

Executive Level Attendees

Chinese Companies and Investors

One-to-one meetings

WHAT

TO

EXPECT

PITCH & MATCH

Help you secure 1-on-1 meeting opportunities with your target audience

APPLY TO PRESENT

GENERAL REGISTRATION

Learn about the rising healthcare market opportunity, innovation and investment trend in China from industry leaders from China

REGISTRATION

INVESTOR REGISTRATION

Qualified investors can request
complimentary registration

REGISTRATION

MEDIA REGISTRATION

Member of the press can request for a complimentary registration

REGISTRATION

Download Sample Attendee List from past China Focus events

Download Sample Attendee List

Download Program from past China Focus events

Download Program

Agenda

Room	Theme	Time
254A	MyBioGate Global Healthcare Innovation Competition	9 AM – 12:30 PM
254A	Pitch & Match	1:00 PM – 3 PM
254B	Exhibition and Partnering	10 AM – 3:30 PM
255	Plenary session (including Simcere Salon)	8:30 AM – 5:20 PM
254 A&B	Reception (sponsored by Simcere Innovation, Inc.)	5:20 PM - 7:00 PM

Time	Plenary session (Room 255)

8:30 AM - 9:10 AM	Opening Remark Keynote: China's Role in Global Life Science and Healthcare Katherine Anderson - Head of U.S. Life Science & Healthcare Relationship Banking, Silicon Valley Bank
9:10 AM - 10:10 AM	Panel 1: Cross-border partnership in a new era of globalization and innovation Moderator: Mark Young - Co-founder & Managing Partner, Bridge Point Capital Panelists: Lei (Geffrey) Gao - Executive VP/Deputy General Manager, Harbin Pharma Qingxi (Charles) Wang - Executive President of International Division and Executive Director of the Board, CSPC Pharmaceutical Group Travis McCready - President & CEO, Massachusetts Life Sciences Center Konstantin Poukalov - Perceptive Advisors
10:10 AM - 10:30 AM	Break
10:30 AM - 11:00 AM	Featured Talk: Regulatory reforms in China and the impact on cross-border partnership in the healthcare industry Haishan Xiong - Senior VP Business Development, FMD K&L
11:00 AM - 12:00 PM	Panel 2: Chinese biopharma’s diverse strategies to meet the domestic and global needs of innovation Moderator: Danhui Wang - Founding Partner, Remedeca Partners LLC Panelists: Xiyong (Sean) Fu - President, Luye Boston R&D LLC Lijun Wu - Chief Scientific Officer, Fosun Pharma US Miguel Forte - CEO, Zelluna Immunotherapy; CCO, the International Society for Cell and Gene Therapy
12:00 PM - 1:00 PM	Lunch break
1:00 PM - 1:20 PM	Featured Talk: Current status and outlook of CAR-T therapy in China Wei (William) Cao - CEO, Gracell Biotechnologies
1:20 PM - 2:10 PM	Panel 3: China’s growing role in a global battle against cancer Moderator: Laura Benjamin - President & CEO, Oncologie Panelists: Xiangyang (Sean) Zhang - CEO, Hengrui Therapeutics Wei (William) Cao - CEO, Gracell Biotechnologies Hua Mu - Chief Medical Officer, Simcere Pharmaceutical Group
2:10 PM - 2:50 PM	Chinese company showcase
2:50 PM - 3:10 PM	Break
3:10 PM - 4:00 PM	Panel 4 (partnering with TORREYA): Winning recipes in a competitive landscape of licensing - What can we learn from the experiences of recent deal makers? Moderator: Jie Liu - Managing Director, Torreya Partners Panelists: Jiawen Han - Head of Business Development (USA), Qilu Pharmaceutical Samuel Murphy - VP and Head of International Business Development, Salubris Pharmaceuticals Anna Vardanyan - Executive Director of Business Development and Alliance Management, Everest Medicines Jack Wu - Head of Business Development (USA), Adlai Nortye Biopharma
4:00 PM - 7:00 PM	SIMCERE SALON (complimentary registration needed) Special Talk: Understanding and curing rare diseases worldwide Harvey Lodish - Founding Partner and Professor, Whitehead Institute of Biomedical Research/MIT Special Talk: PD-1 cancer immunotherapy Gordon Freeman - Professor of Medical Oncology, Dana-Farbar Cancer Institute/ Harvard Medical School Special Talk: The drug regulatory reform and accelerating new drug development in China Alex Xu - Chief Scientist, CDE/NMPA "Simcere Innovation in Boston" Shawn Xu - Executive Director, Simcere Innovation, Inc. Networking (Room 254A&B - drinks and refreshment provided)